Expert Video - How can I choose a clinical trial for AML?

Dr. Sandra Kurtin, expert on acute myeloid leukemia (AML), describes how to choose a clinical trial, or a research study that involves humans. You may want to try a new medication that is not yet available to the public. Your doctor may recommend joining a trial at a specific stage, or phase, of new medication development. Trials have guidelines for who qualifies to be in them, but Dr. Kurtin emphasizes that there is often one that fits your situation and all patients are encouraged to consider a clinical trial.

  • Share with family and friends:

Click here to take our SURVEY
Your feedback is important to us! We will use your feedback to develop future areas of content about AML which will help other patients, caregivers and families.

Please rate this content:

This educational activity has been developed by the Myelodysplastic Syndromes Foundation, Inc. and Mechanisms in Medicine Inc.

This activity is supported by educational grants from AbbVie, Celgene Corporation, Daiichi Sankyo, Jazz Pharmaceuticals and Takeda Oncology.

This website is part of the Animated Patient™ series developed by Mechanisms in Medicine Inc., to provide highly visual formats of learning for patients to improve their understanding, make informed decisions, and partner with their healthcare professionals for optimal outcomes.